药品药物中的NNitrosamine形成:开发和验证一个有偏见的,保守的,预测模型
1Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, United Kingdom.
Journal of pharmaceutical sciences
|November 17, 2025
概括
一个新的动力模型预测了固体药物产品中N-尼托胺的形成. 该模型使用保守假设,倾向于过度预测杂质水平,这对于风险评估非常有用.
科学领域:
- 制药化学 制药化学 制药化学
- 化学动力学 化学动力学
- 药品安全 药品安全
背景情况:
- 监管机构要求对药品中的N-尼托胺进行风险评估.
- 在各种药品中检测到N-尼托胺,这引发了安全问题.
研究的目的:
- 开发和验证一种溶液相运动模型,用于预测固体药物产品中N-尼托拉胺的形成.
- 评估一种保守的动力学模型在药物产品尼托胺风险评估中的有用性.
主要方法:
- 使用和溶液层概念,调整了二次氨基化溶液相运动模型.
- 模型预测与实验测试数据进行了比较,用于特定的N-胺和胺药物物质相关杂质 (NDSRI).
主要成果:
- 动力模型,以保守的假设,始终预测过度N-尼托罗斯胺水平.
- 对酸-4-皮佩里丁和两个NDSRI (酸β-阻断剂,酸胺杂质的酸) 的验证证实了该模型的过度预测倾向.
- 该模型证明了风险评估的有用性,尽管预测过度.
结论:
- 开发的动力模型为N-尼托胺在固体药物产品中的风险评估提供了保守但有用的工具.
- 进一步的模型扩展可以纳入竞争的化反应和反应剂的可用性,以提高准确性.
相关概念视频
2° Amines to N-Nitrosamines: Reaction with NaNO2
5.3K
Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
5.3K
Pharmacokinetic Models: Comparison and Selection Criterion
314
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
314
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
318
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
318
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Clinically Relevant Drug Product Specifications: Methods of Establishment
189
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
189
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
298
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
298


